Neoadjuvant chemotherapy in T3-4 N0-X M0 transitional cell carcinoma of the bladder. Problems of clinical and pathological evaluation of response.
Splinter
T A
TA
University Hospital Dijkzigt, Rotterdam.
ten Kate
F J
FJ
Schröder
F H
FH
Denis
L
L
Newling
D
D
Jones
W G
WG
Jacqmin
D
D
Boeken Kruger
C G
CG
Stoter
G
G
de Voogt
H J
HJ
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D011300:Preoperative Care; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D002945:Cisplatin; D008727:Methotrexate